ARTICLE | Clinical News
Novastan thrombin inhibitor: Began Phase II trial in 120 patients
October 16, 1995 7:00 AM UTC
Texas Biotechnology Corp. (TXB), Houston Product: Novastan thrombin inhibitor Indication: Adjunct to tPA and aspirin in acute myocardial infarction Status: Began Phase II trial in 120 patients ...